ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) YoY Rev. per Sh. Growth : -76.13% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ExpreS2ion Biotech Holding AB's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was -76.13%.

ExpreS2ion Biotech Holding AB's Revenue per Share for the three months ended in Dec. 2024 was kr0.19.

ExpreS2ion Biotech Holding AB YoY Rev. per Sh. Growth Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB YoY Rev. per Sh. Growth Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-77.32

117.56

-63.63

9.05

-75.81

ExpreS2ion Biotech Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-2.68	-74.28	-82.48	-89.05	-76.13

ExpreS2ion Biotech Holding AB YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ExpreS2ion Biotech Holding AB's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(1.134	-	4.688)	/	\| 4.688 \|
=	-75.81 %

ExpreS2ion Biotech Holding AB's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=	(Revenue per Share (Q: Dec. 2024 )	-	Revenue per Share (Q: Dec. 2023 ))	/	\| Revenue per Share (Q: Dec. 2023 )) \|
=	(0.191	-	0.8)	/	\| 0.8 \|
=	-76.13 %

ExpreS2ion Biotech Holding AB YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy; ES2B-I002, a Cytomegalovirus (CMV) vaccine; and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.

ExpreS2ion Biotech Holding AB Headlines

No Headlines